147 related articles for article (PubMed ID: 18158122)
21. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoids and cyclosporine induce apoptosis in mitogen-activated human peripheral mononuclear cells.
Horigome A; Hirano T; Oka K; Takeuchi H; Sakurai E; Kozaki K; Matsuno N; Nagao T; Kozaki M
Immunopharmacology; 1997 Aug; 37(1):87-94. PubMed ID: 9285247
[TBL] [Abstract][Full Text] [Related]
23. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of graft nephrectomy in pre-cyclosporine and cyclosporine era.
Adhikary SD; Viswaroop SB; Kekre NS; Gopalakrishnan G
Urol Int; 2008; 80(1):80-3. PubMed ID: 18204239
[TBL] [Abstract][Full Text] [Related]
26. Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients.
Seckinger J; Sommerer C; Hinkel UP; Hoffmann O; Zeier M; Schwenger V
J Hypertens; 2008 Nov; 26(11):2213-9. PubMed ID: 18854763
[TBL] [Abstract][Full Text] [Related]
27. Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients.
Sommerer C; Morath C; Giese T; Meuer S; Zeier M
Transplant Proc; 2008 Jun; 40(5):1416-8. PubMed ID: 18589120
[TBL] [Abstract][Full Text] [Related]
28. HCV core protein augments cyclosporine immunosuppression.
Kimball P; Verbeke S; Shiffman M
Transplant Proc; 2005 Mar; 37(2):652-3. PubMed ID: 15848490
[TBL] [Abstract][Full Text] [Related]
29. [The immunomodulating action of cyclosporin A in vitro and in vivo on the lymphocytes of patients with alveolitis].
Kosmiadi GA; Abramova ZP; Vaneeva TV; Fomina NM; Gergert VIa; Shmelev EI
Probl Tuberk; 1996; (4):51-3. PubMed ID: 9026809
[TBL] [Abstract][Full Text] [Related]
30. Additional inhibitory effects of intravenous immunoglobulins in combination with cyclosporine A on human T lymphocyte alloproliferative response in vitro.
Schanz U; Hügle T; Gmür J
Transplantation; 1996 Jun; 61(12):1736-40. PubMed ID: 8685953
[TBL] [Abstract][Full Text] [Related]
31. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
32. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
[TBL] [Abstract][Full Text] [Related]
33. Adverse effects on the lipid profile of immunosuppressive regimens: tacrolimus versus cyclosporin measured using C2 levels.
Sánchez Pérez B; Aranda Narváez JM; Suárez Muñoz MA; Fernández Aguilar JL; González Sánchez AJ; Pérez Daga JA; Santoyo Santoyo J
Transplant Proc; 2009 Apr; 41(3):1028-9. PubMed ID: 19376418
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of in vitro immunoglobulin production by a novel immunosuppressive drug brequinar sodium.
Moudgil A; Toyoda M; Wang SJ; Jaffee BD; Cramer DV; Makowka L; Jordan S
Transplant Sci; 1994 Sep; 4(1):116-8. PubMed ID: 7528627
[No Abstract] [Full Text] [Related]
35. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
Yu X; Zhang B; Xing C; Sun B; Liu M; Zhang W; Gu M
Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
[TBL] [Abstract][Full Text] [Related]
36. Recovery of blood mononuclear cell calcineurin activity segregates two populations of renal transplant patients with different sensitivities to cyclosporine inhibition.
Piccinini G; Gaspari F; Signorini O; Remuzzi G; Perico N
Transplantation; 1996 May; 61(10):1526-31. PubMed ID: 8633383
[TBL] [Abstract][Full Text] [Related]
37. Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation.
Li Y; Xue WJ; Tian PX; Ding XM; Yan H; Pan XM; Feng XS
Transplant Proc; 2009 Jun; 41(5):1565-9. PubMed ID: 19545680
[TBL] [Abstract][Full Text] [Related]
38. Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
Clin Transplant; 2008; 22(5):645-50. PubMed ID: 18657156
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
Krämer BK; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Ortuño J; Sester U; Kunzendorf U; Dietl KH; Bonomini V; Rigotti P; Ronco C; Tabernero JM; Rivero M; Banas B; Mühlbacher F; Arias M; Montagnino G;
Nephrol Dial Transplant; 2008 Jul; 23(7):2386-92. PubMed ID: 18258740
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-15 is the main mediator of lymphocyte proliferation in cultures mixed with human kidney tubular epithelial cells.
Lewis E; Weiler M; Chaimovitz C; Douvdevani A
Transplantation; 2001 Sep; 72(5):886-90. PubMed ID: 11571455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
